Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Latest news
Alzheimer’s Gene APOE4 Tied to Tau Protein in the Brain
Phil’s Journal: Navigating the Holidays With Alzheimer’s
An HIV Drug to Treat Alzheimer’s? Researchers See Promising Results in Mice
Phil’s Journal: After My Early Onset Alzheimer’s Diagnosis, Writing About It Became Cathartic
Biogen Cancels Another Dementia Drug in Phase 2 Clinical Trial
$350 Million to Be Given to Alzheimer’s Research in 2020 Funding Bill
Yoga Benefits the Brain and May Reduce Risk of Alzheimer’s
Will Biogen’s Drug Aducanumab Solve the Alzheimer’s Mystery?
There’s More to Alzheimer’s Than Your Genes: Researchers Find Clues By Studying Identical Triplets
Researchers Pinpoint Brain Process That May Lead to Amyloid Buildup
Can Coffee Protect Your Brain From Alzheimer’s?
The Perception of Decline: Life Following a Dual Diagnosis of Alzheimer’s and Lewy Body Dementia
Healthy Blood Vessels, Healthy Brain
For Alzheimer’s Patient, Hope Renewed Following Biogen Announcement
Phil’s Journal: Seeking to Understand the Science Behind Biogen’s Alzheimer’s Drug
Previous
108
109
110
Next
Page load link
Go to Top